col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


72 Results       Page 1

 [1] 
Public Library of Science: PLoS Biology
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―14 Developing inhibitory peptides against SARS-CoV-2 envelope protein Ramsey Bekdash, Kazushige Yoshida, Manoj S. Nair, Lauren Qiu, Johnathan Ahdout, Hsiang-Yi Tsai, et al. (+6)
2 [GO] 2024―Jan―30 Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants Timothy W. Russell, Hermaleigh Townsley, Sam Abbott, Joel Hellewell, Edward J. Carr, Lloyd A. C. Chapman, et al. (+21)
3 [GO] 2023―Nov―28 Resurrection of 2′-5′-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication Spyros Lytras, Arthur Wickenhagen, Elena Sugrue, Douglas G. Stewart, Simon Swingler, Anna Sims, et al. (+7)
4 [GO] 2023―Nov―07 Minding the “T”s beyond the “B”s: Shaping vaccines for future pandemics Shirin Kalimuddin, Eng Eong Ooi
5 [GO] 2023―Aug―22 Metapopulation dynamics of SARS-CoV-2 transmission in a small-scale Amazonian society Thomas S. Kraft, Edmond Seabright, Sarah Alami, Samuel M. Jenness, Paul Hooper, Bret Beheim, et al. (+13)
6 [GO] 2023―Jun―13 DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner Madison S. Strine, Wesley L. Cai, Jin Wei, Mia Madel Alfajaro, Renata B. Filler, Scott B. Biering, et al. (+16)
7 [GO] 2023―Jun―08 Host-specific sensing of coronaviruses and picornaviruses by the CARD8 inflammasome Brian V. Tsu, Rimjhim Agarwal, Nandan S. Gokhale, Jessie Kulsuptrakul, Andrew P. Ryan, Elizabeth J. Fay, et al. (+11)
8 [GO] 2023―May―25 Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England Oliver Eales, David Haw, Haowei Wang, Christina Atchison, Deborah Ashby, Graham S. Cooke, et al. (+8)
9 [GO] 2023―May―25 What’s what in a pandemic? Virus, disease, and societal disaster must be differentiated Alexander E. Gorbalenya, Stanley Perlman
10 [GO] 2023―Apr―12 Genomic surveillance urgently needed to control wheat blast pandemic spreading across continents Johanna Rhodes
11 [GO] 2023―Apr―11 Genomic surveillance uncovers a pandemic clonal lineage of the wheat blast fungus Sergio M. Latorre, Vincent M. Were, Andrew J. Foster, Thorsten Langner, Angus Malmgren, Adeline Harant, et al. (+29)
12 [GO] 2023―Mar―17 CMPK2 is a host restriction factor that inhibits infection of multiple coronaviruses in a cell-intrinsic manner Mingjun Zhu, Jiahuang Lv, Wei Wang, Rongli Guo, Chunyan Zhong, Avan Antia, et al. (+9)
13 [GO] 2023―Feb―09 Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs Lipin Loo, Matthew A. Waller, Cesar L. Moreno, Alexander J. Cole, Alberto Ospina Stella, Oltin-Tiberiu Pop, et al. (+18)
14 [GO] 2023―Feb―06 Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection Alan T. Tang, David W. Buchholz, Katherine M. Szigety, Brian Imbiakha, Siqi Gao, Maxwell Frankfurter, et al. (+17)
15 [GO] 2023―Feb―03 LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein Jarrod Shilts, Thomas W. M. Crozier, Ana Teixeira-Silva, Ildar Gabaev, Pehuén Pereyra Gerber, Edward J. D. Greenwood, et al. (+11)
16 [GO] 2022―Nov―16 SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression Daniela Niemeyer, Saskia Stenzel, Talitha Veith, Simon Schroeder, Kirstin Friedmann, Friderike Weege, et al. (+38)
17 [GO] 2022―Nov―08 Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response Gustavo Garcia, Arjit Vijey Jeyachandran, Yijie Wang, Joseph Ignatius Irudayam, Sebastian Castillo Cario, Chandani Sen, et al. (+12)
18 [GO] 2022―Nov―03 SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir Pinar Mesci, Janaina S. de Souza, Laura Martin-Sancho, Angela Macia, Aurian Saleh, Xin Yin, et al. (+13)
19 [GO] 2022―Oct―13 LRRC15 inhibits SARS-CoV-2 cellular entry in trans Jaewon Song, Ryan D. Chow, Mario Pena-Hernandez, Li Zhang, Skylar A. Loeb, Eui-Young So, et al. (+6)
20 [GO] 2022―Sep―14 SARS-CoV-2 takes the bait: Exosomes as endogenous decoys Sonja Fernbach, Benjamin G. Hale
21 [GO] 2022―Sep―13 ACE2-containing defensosomes serve as decoys to inhibit SARS-CoV-2 infection Krystal L. Ching, Maren de Vries, Juan Gago, Kristen Dancel-Manning, Joseph Sall, William J. Rice, et al. (+11)
22 [GO] 2022―Aug―01 Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells Yanshan Zhu, Keng Yih Chew, Melanie Wu, Anjana C. Karawita, Georgina McCallum, Lauren E. Steele, et al. (+20)
23 [GO] 2022―Jul―27 Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains Sarah M. Roelle, Nidhi Shukla, Anh T. Pham, Anna M. Bruchez, Kenneth A. Matreyek, Xuping Xie
24 [GO] 2022―Jul―05 Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease Idoia Busnadiego, Irene A. Abela, Pascal M. Frey, Daniel A. Hofmaenner, Thomas C. Scheier, Reto A. Schuepbach, et al. (+4)
25 [GO] 2022―May―24 No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination Alice Lu-Culligan, Alexandra Tabachnikova, Eddy Pérez-Then, Maria Tokuyama, Hannah J. Lee, Carolina Lucas, et al. (+19)
26 [GO] 2022―May―16 Why do some coronaviruses become pandemic threats when others do not? Benjamin L. Rice, Justin Lessler, Clifton McKee, C. Jessica E. Metcalf
27 [GO] 2022―May―05 Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates Daniel Y. Zhu, Matthew J. Gorman, Dansu Yuan, Jingyou Yu, Noe B. Mercado, Katherine McMahan, et al. (+20)
28 [GO] 2022―Mar―31 Variable susceptibility of intestinal organoid-derived monolayers to SARS-CoV-2 infection Kyung Ku Jang, Maria E. Kaczmarek, Simone Dallari, Ying-Han Chen, Takuya Tada, Jordan Axelrad, et al. (+4)
29 [GO] 2022―Feb―10 SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort Emilie Finch, Rachel Lowe, Stephanie Fischinger, Michael de St Aubin, Sameed M. Siddiqui, Diana Dayal, et al. (+13)
30 [GO] 2022―Feb―01 Tracking changes between preprint posting and journal publication during a pandemic Liam Brierley, Federico Nanni, Jessica K. Polka, Gautam Dey, Máté Pálfy, Nicholas Fraser, et al. (+2)
31 [GO] 2021―Dec―28 A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets Annika Kratzel, Jenna N. Kelly, Philip V’kovski, Jasmine Portmann, Yannick Brüggemann, Daniel Todt, et al. (+11)
32 [GO] 2021―Dec―21 Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses Vanessa Herder, Kieran Dee, Joanna K. Wojtus, Ilaria Epifano, Daniel Goldfarb, Christoforos Rozario, et al. (+17)
33 [GO] 2021―Dec―21 Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2 Gianni M. Castiglione, Lingli Zhou, Zhenhua Xu, Zachary Neiman, Chien-Fu Hung, Elia J. Duh, Andreas Hejnol
34 [GO] 2021―Dec―16 Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus Fatima Amanat, Shirin Strohmeier, Philip Meade, Nicholas Dambrauskas, Barbara Mühlemann, Derek J. Smith, et al. (+5)
35 [GO] 2021―Nov―04 Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge Antonio Muruato, Michelle N. Vu, Bryan A. Johnson, Meredith E. Davis-Gardner, Abigail Vanderheiden, Kumari Lokugamage, et al. (+14)
36 [GO] 2021―Oct―11 SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA Amanda Jack, Luke S. Ferro, Michael J. Trnka, Eddie Wehri, Amrut Nadgir, Xammy Nguyenla, et al. (+6)
37 [GO] 2021―Aug―06 Challenges in interpreting cytokine data in COVID-19 affect patient care and management Stephen Y. Wang, Takehiro Takahashi, Alexander B. Pine, William E. Damsky, Michael Simonov, Yanhua Zhang, et al. (+8)
38 [GO] 2021―Jul―12 Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies Stephen M. Kissler, Joseph R. Fauver, Christina Mack, Scott W. Olesen, Caroline Tai, Kristin Y. Shiue, et al. (+13)
39 [GO] 2021―Jun―18 The landscape of antibody binding in SARS-CoV-2 infection Anna S. Heffron, Sean J. McIlwain, Maya F. Amjadi, David A. Baker, Saniya Khullar, Tammy Armbrust, et al. (+8)
40 [GO] 2021―Jun―17 Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making James D. Nichols, Tiffany L. Bogich, Emily Howerton, Ottar N. Bjørnstad, Rebecca K. Borchering, Matthew Ferrari, et al. (+9)
41 [GO] 2021―May―25 A generation of junior faculty is at risk from the impacts of COVID-19 Tiffany Lowe-Power, Louise Dyson, Abigail M. Polter
42 [GO] 2021―May―07 Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2 Chantal B. F. Vogels, Mallery I. Breban, Isabel M. Ott, Tara Alpert, Mary E. Petrone, Anne E. Watkins, et al. (+34)
43 [GO] 2021―May―07 Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes Dan Fu, Guangshun Zhang, Yuhui Wang, Zheng Zhang, Hengrui Hu, Shu Shen, et al. (+32)
44 [GO] 2021―Apr―29 Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: Testing frequency and public health messaging is key Jack Ferguson, Steven Dunn, Angus Best, Jeremy Mirza, Benita Percival, Megan Mayhew, et al. (+12)
45 [GO] 2021―Apr―29 Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies Xing Zhu, Dhiraj Mannar, Shanti S. Srivastava, Alison M. Berezuk, Jean-Philippe Demers, James W. Saville, et al. (+8)
46 [GO] 2021―Apr―26 The first few days of a SARS-CoV-2 infection viewed at single-cell resolution Tom Gallagher, Paul B. McCray
47 [GO] 2021―Apr―21 Evaluation of COVID-19 vaccination strategies with a delayed second dose Seyed M. Moghadas, Thomas N. Vilches, Kevin Zhang, Shokoofeh Nourbakhsh, Pratha Sah, Meagan C. Fitzpatrick, et al. (+2)
48 [GO] 2021―Apr―02 The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape Nicholas Fraser, Liam Brierley, Gautam Dey, Jessica K. Polka, Máté Pálfy, Federico Nanni, et al. (+2)
49 [GO] 2021―Mar―29 Disparate temperature-dependent virus-host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium Philip V’kovski, Mitra Gultom, Jenna N. Kelly, Silvio Steiner, Julie Russeil, Bastien Mangeat, et al. (+17)
50 [GO] 2021―Mar―24 SARS-CoV-2 variants reveal features critical for replication in primary human cells Marie O. Pohl, Idoia Busnadiego, Verena Kufner, Irina Glas, Umut Karakus, Stefan Schmutz, et al. (+7)
51 [GO] 2021―Mar―22 A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2 Kwang Su Kim, Keisuke Ejima, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, et al. (+9)
52 [GO] 2021―Mar―17 Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes Neal G. Ravindra, Mia Madel Alfajaro, Victor Gasque, Nicholas C. Huston, Han Wan, Klara Szigeti-Buck, et al. (+22)
53 [GO] 2021―Mar―12 Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen Oscar A. MacLean, Spyros Lytras, Steven Weaver, Joshua B. Singer, Maciej F. Boni, Philippe Lemey, et al. (+3)
54 [GO] 2021―Mar―09 Rebuild the Academy: Supporting academic mothers during COVID-19 and beyond Robinson W. Fulweiler, Sarah W. Davies, Jennifer F. Biddle, Amy J. Burgin, Emily H. G. Cooperdock, Torrance C. Hanley, et al. (+7)
55 [GO] 2021―Mar―08 Racism, disease, and vaccine refusal: People of color are dying for access to COVID-19 vaccines Susan M. Reverby
56 [GO] 2021―Feb―25 A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research Suzannah J. Rihn, Andres Merits, Siddharth Bakshi, Matthew L. Turnbull, Arthur Wickenhagen, Akira J. T. Alexander, et al. (+77)
57 [GO] 2021―Feb―17 COVID-19 induces a hyperactive phenotype in circulating platelets Shane P. Comer, Sarah Cullivan, Paulina B. Szklanna, Luisa Weiss, Steven Cullen, Sarah Kelliher, et al. (+15)
58 [GO] 2020―Dec―21 The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins Carina Conceicao, Nazia Thakur, Stacey Human, James T. Kelly, Leanne Logan, Dagmara Bialy, et al. (+18)
59 [GO] 2020―Dec―15 A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection Martin A. M. Reijns, Louise Thompson, Juan Carlos Acosta, Holly A. Black, Francisco J. Sanchez-Luque, Austin Diamond, et al. (+33)
60 [GO] 2020―Dec―15 Rapid detection of SARS-CoV-2 with CRISPR-Cas12a Dan Xiong, Wenjun Dai, Jiaojiao Gong, Guande Li, Nansong Liu, Wei Wu, et al. (+12)
61 [GO] 2020―Nov―12 Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control Benjamin M. Althouse, Edward A. Wenger, Joel C. Miller, Samuel V. Scarpino, Antoine Allard, Laurent Hébert-Dufresne, Hao Hu
62 [GO] 2020―Nov―09 Monitor for COVID-19 vaccine resistance evolution during clinical trials David A. Kennedy, Andrew F. Read
63 [GO] 2020―Nov―06 A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19 Yadi Zhou, Yuan Hou, Jiayu Shen, Reena Mehra, Asha Kallianpur, Daniel A. Culver, et al. (+13)
64 [GO] 2020―Oct―16 The COVID-19 response illustrates that traditional academic reward structures and metrics do not reflect crucial contributions to modern science Adam J. Kucharski, Sebastian Funk, Rosalind M. Eggo
65 [GO] 2020―Oct―07 Detection of SARS-CoV-2 RNA by multiplex RT-qPCR Eriko Kudo, Benjamin Israelow, Chantal B. F. Vogels, Peiwen Lu, Anne L. Wyllie, Maria Tokuyama, et al. (+16)
66 [GO] 2020―Oct―02 Direct RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swabs without an RNA extraction step Emily A. Bruce, Meei-Li Huang, Garrett A. Perchetti, Scott Tighe, Pheobe Laaguiby, Jessica J. Hoffman, et al. (+14)
67 [GO] 2020―Sep―08 In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age Nicole A. P. Lieberman, Vikas Peddu, Hong Xie, Lasata Shrestha, Meei-Li Huang, Megan C. Mears, et al. (+10)
68 [GO] 2020―Aug―27 Recommendations for future university pandemic responses: What the first COVID-19 shutdown taught us Carolyn Coyne, Jimmy D. Ballard, Ira J. Blader
69 [GO] 2020―Aug―21 Real-time public health communication of local SARS-CoV-2 genomic epidemiology Chaney C. Kalinich, Cole G. Jensen, Peter Neugebauer, Mary E. Petrone, Mario Peña-Hernández, Isabel M. Ott, et al. (+6)
70 [GO] 2020―Aug―06 Integrative illustration for coronavirus outreach David S. Goodsell, Maria Voigt, Christine Zardecki, Stephen K. Burley
71 [GO] 2020―Jun―08 A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis Eric J. Snijder, Ronald W. A. L. Limpens, Adriaan H. de Wilde, Anja W. M. de Jong, Jessika C. Zevenhoven-Dobbe, Helena J. Maier, et al. (+4)
72 [GO] 2020―Apr―24 Leveraging open hardware to alleviate the burden of COVID-19 on global health systems Andre Maia Chagas, Jennifer C. Molloy, Lucia L. Prieto-Godino, Tom Baden
 [1] 

72 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec